Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 80: 760-764, 1996;
8750-7587/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koistinen, H.
Right arrow Articles by Seppala, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koistinen, H.
Right arrow Articles by Seppala, M.

Journal of Applied Physiology, Vol 80, Issue 3 760-764, Copyright © 1996 by American Physiological Society


ARTICLES

Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels

H. Koistinen, R. Koistinen, L. Selenius, Q. Ylikorkala and M. Seppala
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.

Acute physical exercise increases growth hormone (GH) secretion, and GH regulates the expression of insulin-like growth factor I (IGF-I) and IGF-binding protein (IGFBP) 3. IGFBP-1 is a local modulator of IGF activity with rapid dynamic regulation that is downregulated by insulin. The IGF system mediates the metabolic actions of GH, and possibly it regulates glucose metabolism. We hypothesize that strenuous exercise causes changes in the IGF system. We studied the effects of the marathon run on the circulating levels of IGF-I, IGFBP-1, IGFBP-3, and insulin in 23 participants. Immediately after the run, the most striking change was an 11.6-fold median increase in serum IGFBP-1 level (from 63.7 +/- 50.5 to 736 +/- 408 micrograms/l; P < 0.001). Because the insulin level remained unchanged, the elevation of serum IGFBP-1 level cannot be explained by changes in insulin. One day after the run, the IGFBP-1 level had returned to baseline. The physiological role of this increment could be the inhibition of hypoglycemic effects of IGF-I and/or regulation of glucose availability to the muscles. The changes in IGF-I and IGFBP-3 levels were less dramatic: the IGF-I and IGFBP-3 levels were lower 1 and 3 days after the run. This report provides an important basis for authentic effects of strenuous exercise on the IGF-system.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Gibney, M.-L. Healy, and P. H. Sonksen
The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport
Endocr. Rev., October 1, 2007; 28(6): 603 - 624.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. L. Olesen, K. M. Heinemeier, C. Gemmer, M. Kjaer, A. Flyvbjerg, and H. Langberg
Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis
J Appl Physiol, January 1, 2007; 102(1): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Stokes, M. Nevill, J. Frystyk, H. Lakomy, and G. Hall
Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts
J Appl Physiol, October 1, 2005; 99(4): 1254 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
M Elloumi, N El Elj, M Zaouali, F Maso, E Filaire, Z Tabka, and G Lac
IGFBP-3, a sensitive marker of physical training and overtraining
Br. J. Sports Med., September 1, 2005; 39(9): 604 - 610.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kalme, M. Seppala, Q. Qiao, R. Koistinen, A. Nissinen, M. Harrela, M. Loukovaara, P. Leinonen, and J. Tuomilehto
Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1550 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. R. Kraemer, R. J. Durand, E. O. Acevedo, L. G. Johnson, G. R. Kraemer, E. P. Hebert, and V. D. Castracane
Rigorous Running Increases Growth Hormone and Insulin-Like Growth Factor-I Without Altering Ghrelin
Experimental Biology and Medicine, March 1, 2004; 229(3): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Jakubowicz, P. A. Essah, M. Seppala, S. Jakubowicz, J.-P. Baillargeon, R. Koistinen, and J. E. Nestler
Reduced Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein-1 in Women with Polycystic Ovary Syndrome during First Trimester of Pregnancy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 833 - 839.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Kajantie, C. H. D. Fall, M. Seppala, R. Koistinen, L. Dunkel, H. Yliharsila, C. Osmond, S. Andersson, D. J. P. Barker, T. Forsen, et al.
Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-1 in Elderly People: Relationships with Cardiovascular Risk Factors, Body Composition, Size at Birth, and Childhood Growth
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. S. Leinonen, J. T. Salonen, R. M. Salonen, R. A. Koistinen, P. J. Leinonen, S. S. Sarna, and M.-R. Taskinen
Reduced IGFBP-1 Is Associated With Thickening of the Carotid Wall in Type 2 Diabetes
Diabetes Care, October 1, 2002; 25(10): 1807 - 1812.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-M. Lavoie, Y. Fillion, K. Couturier, and P. Corriveau
Exercise Effects on Muscle Insulin Signaling and Action: Selected Contribution: Evidence that the decrease in liver glycogen is associated with the exercise-induced increase in IGFBP-1
J Appl Physiol, August 1, 2002; 93(2): 798 - 804.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. TIRAKITSOONTORN, E. NUSSBAUM, C. MOSER, M. HILL, and D. M. COOPER
Fitness, Acute Exercise, and Anabolic and Catabolic Mediators in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1432 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
J L Chicharro, A Lopez-Calderon, J Hoyos, A I Martin-Velasco, G Villa, M A Villanua, and A Lucia
Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3
Br. J. Sports Med., October 1, 2001; 35(5): 303 - 307.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. G. Anthony, J. C. Anthony, M. S. Lewitt, S. M. Donovan, and D. K. Layman
Time course changes in IGFBP-1 after treadmill exercise and postexercise food intake in rats
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E650 - E656.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. L. Waters, C. R. Qualls, R. Dorin, J. D. Veldhuis, and R. N. Baumgartner
Increased Pulsatility, Process Irregularity, and Nocturnal Trough Concentrations of Growth Hormone in Amenorrheic Compared to Eumenorrheic Athletes
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1013 - 1019.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Jakubowicz, M. Seppälä, S. Jakubowicz, O. Rodriguez-Armas, A. Rivas-Santiago, H. Koistinen, R. Koistinen, and J. E. Nestler
Insulin Reduction with Metformin Increases Luteal Phase Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein 1 Concentrations and Enhances Uterine Vascularity and Blood Flow in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1126 - 1133.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Dall, K. H. W. Lange, M. Kjær, J. O. L. Jørgensen, J. S. Christiansen, H. Ørskov, and A. Flyvbjerg
No Evidence of Insulin-Like Growth Factor-Binding Protein 3 Proteolysis during a Maximal Exercise Test in Elite Athletes
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 669 - 674.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Wallace, R. C. Cuneo, R. Baxter, H. Orskov, N. Keay, C. Pentecost, R. Dall, T. Rosen, J. O. Jorgensen, A. Cittadini, et al.
Responses of the Growth Hormone (GH) and Insulin-Like Growth Factor Axis to Exercise, GH Administration, and GH Withdrawal in Trained Adult Males: A Potential Test for GH Abuse in Sport
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3591 - 3601.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. P. Koziris, R. C. Hickson, R. T. Chatterton Jr., R. T. Groseth, J. M. Christie, D. G. Goldflies, and T. G. Unterman
Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
J Appl Physiol, April 1, 1999; 86(4): 1436 - 1442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online